Fuller & Thaler Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-73
| Closed | -$1.35K | – | 563 |
|
|
2024
Q1 | $1.35K | Sell |
73
-641,112
| -100% | -$11.9M | ﹤0.01% | 533 |
|
|
2023
Q4 | $20.1M | Buy |
+641,185
| New | +$20.1M | 0.1% | 203 |
|
|
2018
Q4 | – | Sell |
-437,255
| Closed | -$9.08M | – | 460 |
|
|
2018
Q3 | $9.08M | Buy |
+437,255
| New | +$9.08M | 0.09% | 166 |
|